Knowledge graph-based recommendation framework identifies drivers of resistance in EGFR mutant non-small cell lung cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Knowledge graph-based recommendation framework identifies drivers of resistance in EGFR mutant non-small cell lung cancer
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-03-29
DOI
10.1038/s41467-022-29292-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MEK inhibitors for the treatment of non-small cell lung cancer
- (2021) Jing Han et al. Journal of Hematology & Oncology
- The emerging role of the KCTD proteins in cancer
- (2021) Annapaola Angrisani et al. Cell Communication and Signaling
- Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway
- (2020) Kari J. Kurppa et al. CANCER CELL
- Inactivation of NF1 promotes resistance to EGFR inhibition in KRAS/NRAS/BRAFV600-wildtype colorectal cancer
- (2020) Alexandros Georgiou et al. MOLECULAR CANCER RESEARCH
- Enhanced DNA-repair capacity and resistance to chemically induced carcinogenesis upon deletion of the phosphatase regulator NIPP1
- (2020) Iris Verbinnen et al. Oncogenesis
- GCN-CNN: A Novel Deep Learning Method for Prioritizing lncRNA Target Genes
- (2020) Tianyi Zhao et al. BIOINFORMATICS
- Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes
- (2020) Yuxin Mu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Immediate Adaptation Analysis Implicates BCL6 as an EGFR-TKI Combination Therapy Target in NSCLC
- (2020) Yan Zhou Tran et al. MOLECULAR & CELLULAR PROTEOMICS
- A machine learning Automated Recommendation Tool for synthetic biology
- (2020) Tijana Radivojević et al. Nature Communications
- EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells
- (2020) Hao Gong et al. BMC CANCER
- Machine learning and chemico-genomics approach defines and predicts cross-talk of Hippo and MAPK pathways
- (2020) Trang H Pham et al. Cancer Discovery
- A deep learning model based on sparse auto-encoder for prioritizing cancer-related genes and drug target combinations
- (2019) Ji-Wei Chang et al. CARCINOGENESIS
- Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
- (2019) Fiona M. Behan et al. NATURE
- Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance Induced by Membranous/Cytoplasmic/Nuclear Translocation of Epidermal Growth Factor Receptor
- (2019) Xuezhu Rong et al. Journal of Thoracic Oncology
- Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
- (2019) Alessandro Leonetti et al. BRITISH JOURNAL OF CANCER
- An adaptive weight vector guided evolutionary algorithm for preference-based multi-objective optimization
- (2019) Feng Wang et al. Swarm and Evolutionary Computation
- P2.01-22 ORCHARD: A Phase II Platform Study in Patients with Advanced NSCLC Who Have Progressed on First-Line Osimertinib Therapy
- (2019) H. Yu et al. Journal of Thoracic Oncology
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
- (2019) Suresh S. Ramalingam et al. NEW ENGLAND JOURNAL OF MEDICINE
- Billion-Scale Similarity Search with GPUs
- (2019) Jeff Johnson et al. IEEE Transactions on Big Data
- Molecular mechanisms of acquired resistance to third-generation EGFR-TKIs in EGFR T790M-mutant lung cancer
- (2018) C Ricordel et al. ANNALS OF ONCOLOGY
- Predicting Cancer Drug Response using a Recommender System
- (2018) Chayaporn Suphavilai et al. BIOINFORMATICS
- MetaboRank: network-based recommendation system to interpret and enrich metabolomics results
- (2018) Clément Frainay et al. BIOINFORMATICS
- Scuba: scalable kernel-based gene prioritization
- (2018) Guido Zampieri et al. BMC BIOINFORMATICS
- Resistance to gefitinib and cross-resistance to irreversible EGFR-TKIs mediated by disruption of the Keap1-Nrf2 pathway in human lung cancer cells
- (2018) Seong-Hee Park et al. FASEB JOURNAL
- Approaches to target tractability assessment – a practical perspective
- (2018) Kristin K. Brown et al. MedChemComm
- Prioritizing network communities
- (2018) Marinka Zitnik et al. Nature Communications
- YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting
- (2018) Federica Lo Sardo et al. Cancers
- Two Decades of Recommender Systems at Amazon.com
- (2017) Brent Smith et al. IEEE INTERNET COMPUTING
- Knowledge Graph Embedding: A Survey of Approaches and Applications
- (2017) Quan Wang et al. IEEE TRANSACTIONS ON KNOWLEDGE AND DATA ENGINEERING
- Osimertinib in Pretreated T790M-Positive Advanced Non–Small-Cell Lung Cancer: AURA Study Phase II Extension Component
- (2017) James Chih-Hsin Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- ranger: A Fast Implementation of Random Forests for High Dimensional Data in C++ and R
- (2017) Marvin N. Wright et al. Journal of Statistical Software
- Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma
- (2017) Yoshiteru Ohata et al. MOLECULAR CANCER THERAPEUTICS
- Genetic wiring maps of single-cell protein states reveal an off-switch for GPCR signalling
- (2017) Markus Brockmann et al. NATURE
- Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens
- (2017) Traver Hart et al. G3-Genes Genomes Genetics
- Systematic integration of biomedical knowledge prioritizes drugs for repurposing
- (2017) Daniel Scott Himmelstein et al. eLife
- A brief introduction to weakly supervised learning
- (2017) Zhi-Hua Zhou National Science Review
- A large-scale benchmark of gene prioritization methods
- (2017) Dimitri Guala et al. Scientific Reports
- MultiQC: summarize analysis results for multiple tools and samples in a single report
- (2016) Philip Ewels et al. BIOINFORMATICS
- BAGEL: a computational framework for identifying essential genes from pooled library screens
- (2016) Traver Hart et al. BMC BIOINFORMATICS
- The challenges of tumor genetic diversity
- (2016) Edmund A. Mroz et al. CANCER
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non‐coding RNA and synonymous mutations
- (2016) Sven Diederichs et al. EMBO Molecular Medicine
- Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
- (2016) Glenwood Goss et al. LANCET ONCOLOGY
- Exploiting Explicit and Implicit Feedback for Personalized Ranking
- (2016) Gai Li et al. MATHEMATICAL PROBLEMS IN ENGINEERING
- A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
- (2016) Konstantinos Tzelepis et al. Cell Reports
- Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models
- (2015) C. A. Eberlein et al. CANCER RESEARCH
- Childhood leukemia and residential proximity to industrial and urban sites
- (2015) Javier García-Pérez et al. ENVIRONMENTAL RESEARCH
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
- (2015) Silvana Konermann et al. NATURE
- EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function
- (2015) Janyaporn Phuchareon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heterogeneous Network Edge Prediction: A Data Integration Approach to Prioritize Disease-Associated Genes
- (2015) Daniel S. Himmelstein et al. PLoS Computational Biology
- Ranking, selecting, and prioritising genes with desirability functions
- (2015) Stanley E. Lazic PeerJ
- AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
- (2014) D. A. E. Cross et al. Cancer Discovery
- Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer
- (2014) E. C. de Bruin et al. Cancer Discovery
- Dynamic regulation of genome-wide pre-mRNA splicing and stress tolerance by the Sm-like protein LSm5 in Arabidopsis
- (2014) Peng Cui et al. GENOME BIOLOGY
- A new scalarization and numerical method for constructing the weak Pareto front of multi-objective optimization problems
- (2011) Joydeep Dutta et al. OPTIMIZATION
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now